Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Cancer [clinicaltrials:NCT00003732]
Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Cancer [clinicaltrials:NCT00003732]
Bio2RDF identifier
NCT00003732
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00003732
identifiers.org URI
anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
RATIONALE: Drugs used i ...... tage IV ovarian
cancer.
brief title [clinicaltrials_vocabulary:brief-title]
Combination Chemotherapy in Tr ...... II, or Stage IV Ovarian Cancer
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
completion date [clinicaltrials_vocabulary:completion-date]
2005-09-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES:
- ...... I closed to accrual 12/21/00)
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
1999-11-01T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
stage IIB ovarian epithelial cancer
stage IIC ovarian epithelial cancer
stage IIIA ovarian epithelial cancer
stage IIIB ovarian epithelial cancer
stage IIIC ovarian epithelial cancer
stage IV ovarian epithelial cancer
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2013-08-09T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00003732
official title [clinicaltrials_vocabulary:official-title]
A Phase I/II Study to Determin ...... er Stages IIb, IIc, III and IV
org study id [clinicaltrials_vocabulary:org-study-id]
DAN-104864/373
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
secondary id [clinicaltrials_vocabulary:secondary-id]
CDR0000066847
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
1998-09-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2002-07-01T00:00:00Z
identifier
clinicaltrials:NCT00003732
title
Combination Chemotherapy in Tr ...... II, or Stage IV Ovarian Cancer
@en
type
label
Combination Chemotherapy in Tr ...... r [clinicaltrials:NCT00003732]
@en